Mingqi Xie

1.8k total citations
34 papers, 1.3k citations indexed

About

Mingqi Xie is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mingqi Xie has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Surgery and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mingqi Xie's work include CRISPR and Genetic Engineering (13 papers), Pancreatic function and diabetes (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Mingqi Xie is often cited by papers focused on CRISPR and Genetic Engineering (13 papers), Pancreatic function and diabetes (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Mingqi Xie collaborates with scholars based in China, Switzerland and France. Mingqi Xie's co-authors include Martin Fussenegger, Haifeng Ye, Ghislaine Charpin‐El Hamri, Shuai Xue, Pratik Saxena, Martin Fussenegger, Jiawei Shao, Jianli Yin, Claude Lormeau and Hui Wang and has published in prestigious journals such as Science, Cell and Nucleic Acids Research.

In The Last Decade

Mingqi Xie

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingqi Xie China 17 849 397 254 192 177 34 1.3k
Ghislaine Charpin‐El Hamri France 20 1.4k 1.7× 365 0.9× 147 0.6× 202 1.1× 161 0.9× 28 1.8k
Pratik Saxena Switzerland 11 1.0k 1.2× 257 0.6× 129 0.5× 107 0.6× 141 0.8× 16 1.3k
Haifeng Ye China 24 1.4k 1.7× 641 1.6× 647 2.5× 195 1.0× 229 1.3× 55 2.2k
Jeong Ah Kim South Korea 24 1.1k 1.3× 890 2.2× 152 0.6× 162 0.8× 140 0.8× 64 2.3k
Bin Du China 22 780 0.9× 322 0.8× 98 0.4× 149 0.8× 79 0.4× 45 1.6k
Mi‐Ok Lee South Korea 24 1.1k 1.3× 379 1.0× 126 0.5× 248 1.3× 274 1.5× 65 1.9k
Quyen Q. Hoang United States 18 884 1.0× 195 0.5× 188 0.7× 146 0.8× 40 0.2× 34 1.8k
Marie Daoud‐El Baba Switzerland 14 1.2k 1.5× 334 0.8× 252 1.0× 77 0.4× 84 0.5× 19 1.5k
Fengqiao Li China 28 1.2k 1.4× 343 0.9× 185 0.7× 169 0.9× 90 0.5× 36 2.1k
Simon Ausländer Switzerland 18 1.7k 2.0× 285 0.7× 125 0.5× 108 0.6× 46 0.3× 27 1.9k

Countries citing papers authored by Mingqi Xie

Since Specialization
Citations

This map shows the geographic impact of Mingqi Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqi Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqi Xie more than expected).

Fields of papers citing papers by Mingqi Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingqi Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqi Xie. The network helps show where Mingqi Xie may publish in the future.

Co-authorship network of co-authors of Mingqi Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Mingqi Xie. A scholar is included among the top collaborators of Mingqi Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqi Xie. Mingqi Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Mingqi, et al.. (2026). De novo design of small molecule–regulated protein oligomers. Science. 391(6780). eady6017–eady6017.
2.
Li, Shichao, et al.. (2025). Regulation of therapeutic protein release in response to circadian biomarkers. Nature Communications. 16(1). 9812–9812.
3.
Jiang, Jian, et al.. (2025). Programmable solid-state condensates for spatiotemporal control of mammalian gene expression. Nature Chemical Biology. 21(9). 1457–1466. 5 indexed citations
4.
Xue, Shuai, et al.. (2025). Nitroglycerin-responsive gene switch for the on-demand production of therapeutic proteins. Nature Biomedical Engineering. 9(7). 1129–1143. 1 indexed citations
5.
Huang, Jinbo, et al.. (2025). Aspirin-responsive gene switch regulating therapeutic protein expression. Nature Communications. 16(1). 2028–2028. 2 indexed citations
6.
Zhang, Lihang, Xinyuan Qiu, Yuting Zhou, et al.. (2025). A trigger-inducible split-Csy4 architecture for programmable RNA modulation. Nucleic Acids Research. 53(2). 2 indexed citations
7.
Xie, Mingqi, et al.. (2024). Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control. Science Advances. 10(8). eadj6251–eadj6251. 43 indexed citations
8.
Wang, Hui, Mingqi Xie, Giorgio Rizzi, et al.. (2022). Identification of Sclareol As a Natural Neuroprotective Cav1.3‐Antagonist Using Synthetic Parkinson‐Mimetic Gene Circuits and Computer‐Aided Drug Discovery. Advanced Science. 9(7). e2102855–e2102855. 15 indexed citations
9.
Strittmatter, Tobias, et al.. (2021). Gene switch for l‐glucose‐induced biopharmaceutical production in mammalian cells. Biotechnology and Bioengineering. 118(6). 2220–2233. 5 indexed citations
10.
Xie, Mingqi, et al.. (2020). Engineering precision therapies: lessons and motivations from the clinic. PubMed. 6(1). ysaa024–ysaa024. 6 indexed citations
11.
Krawczyk, Krzysztof, Shuai Xue, P. Buchmann, et al.. (2020). Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science. 368(6494). 993–1001. 143 indexed citations
12.
Bai, Peng, Ying Liu, Shuai Xue, et al.. (2019). A fully human transgene switch to regulate therapeutic protein production by cooling sensation. Nature Medicine. 25(8). 1266–1273. 44 indexed citations
13.
Wang, Hui, Mingqi Xie, Ghislaine Charpin‐El Hamri, Haifeng Ye, & Martin Fussenegger. (2018). Treatment of chronic pain by designer cells controlled by spearmint aromatherapy. Nature Biomedical Engineering. 2(2). 114–123. 41 indexed citations
14.
Xie, Mingqi & Martin Fussenegger. (2018). Designing cell function: assembly of synthetic gene circuits for cell biology applications. Nature Reviews Molecular Cell Biology. 19(8). 507–525. 208 indexed citations
15.
Bojar, Daniel, Leo Scheller, Ghislaine Charpin‐El Hamri, Mingqi Xie, & Martin Fussenegger. (2018). Caffeine-inducible gene switches controlling experimental diabetes. Nature Communications. 9(1). 2318–2318. 58 indexed citations
16.
Bai, Peng, Anne-Kathrin Woischnig, Ghislaine Charpin‐El Hamri, et al.. (2018). Immunomimetic Designer Cells Protect Mice from MRSA Infection. Cell. 174(2). 259–270.e11. 63 indexed citations
17.
Shao, Jiawei, Shuai Xue, Guiling Yu, et al.. (2017). Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice. Science Translational Medicine. 9(387). 165 indexed citations
18.
Xie, Mingqi, et al.. (2016). Synthetic biology — application-oriented cell engineering. Current Opinion in Biotechnology. 40. 139–148. 33 indexed citations
19.
Ye, Haifeng, Mingqi Xie, Shuai Xue, et al.. (2016). Self-adjusting synthetic gene circuit for correcting insulin resistance. Nature Biomedical Engineering. 1(1). 5–5. 87 indexed citations
20.
Xie, Mingqi, Haifeng Ye, Ghislaine Charpin‐El Hamri, & Martin Fussenegger. (2014). Antagonistic control of a dual-input mammalian gene switch by food additives. Nucleic Acids Research. 42(14). e116–e116. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026